Detected in the ALL borderland cohort were genes involved in epigenetic regulation at the next level of clinical significance, including DNMT3A, TET2, and WT1. These genes were observed harboring variants with mutational significance in Tier X and Tier 3, respectively (Figure 2). This evidence concerns the gene TET2 and acute lymphoblastic leukemia.